Living with a functional gut disorder can feel unpredictable and exhausting — and it can take a real toll on daily life. Gut-directed hypnotherapy, used alongside conventional medical treatment, is a specifically designed treatment for conditions like IBS, with research showing significant symptom improvement.
 

Understanding the Condition

Gastrointestinal disorders are complex — causes and symptoms vary from person to person. Sufferers may experience abdominal pain, bloating, distension, and disordered bowel habits such as diarrhoea or constipation, which can alternate unpredictably.

These symptoms can affect far more than the gut. Living with an unpredictable condition often means adapting daily life around it — limiting activities, missing work, or avoiding social situations — which can, in turn, take a toll on mental wellbeing and increase stress and anxiety.

Hypnotherapy and CBT offer a proven, evidence-based way to help manage these uncontrollable, painful and disruptive symptoms.
 

How the Treatment Works
Gut-directed hypnosis and CBT work together to address the miscommunication between gut and brain that drives many of these symptoms. Using suggestion, imagery, relaxation and cognitive restructuring, treatment works to calm gut hypersensitivity and build healthy coping strategies — helping to ease symptoms while addressing the stress, anxiety and unhelpful thought patterns that so often develop alongside a long-term condition.
 

 

The Evidence
A landmark study following 1,000 adult patients through gut-directed hypnotherapy found meaningful, lasting results:

- **60–70%** of participants had a positive response to treatment
- **76%** reported a significant reduction in symptom severity
- **67%** reported at least a 30% reduction in pain
- **59%** were able to stop or reduce their medication
- **83%** of responders remained well between 1–5 years after treatment

*Miller V, Carruthers HR, Morris J, Hasan SS, Archbold S, Whorwell PJ. Hypnotherapy for irritable bowel syndrome: an audit of one thousand adult patients. Aliment Pharmacol Ther. 2015.*

​